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useful to reconsider the need for surgical intervention in patients
with meningeal diverticula.
Conclusions: Meningeal diverticula, even if rare, are possible causes
of SIH and medical treatment could be effective in such cases, since
surgery is not always needed.
Consent for publication: the patient signed a written informed consent
for the publication of this case report.
[1] W.I. Schievink, M.M. Maya, C. Louy, F.G. Moser, J. Tourje. Diagnostic Criteria
for Spontaneous Spinal CSF Leaks and Intracranial Hypotension. AJNR Am J
Neuroradiol 29:853–56, May 2008.
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Objectives: To estimate the average annual cost per patient and the
impact on work t of migraine in Spain.
Material and Method: This is a prospective, online, anonymous,
cross-sectional survey, conducted between June and September
2017, promoted by the Spanish Association of Patients with Head-
ache (AEPAC) within the framework of the Spanish Atlas of Migraine
2018. People who completed the survey answered questions in rela-
tion to their migraine. A distinction was made between chronic mi-
graine (CM) and episodic migraine (EM), considering the monthly
headache days declared by patients. The economic burden of mi-
graine was evaluated: direct health costs (including visits to special-
ists, medical tests, emergency visits, hospital admissions and
medication), indirect costs (lost labor productivity), and those as-
sumed by the migraineur. The labor consequences of migraine over
the last year were analyzed. Chi-square and Mann- Whitney tests
were used as contrast tests. Ethics Approval: A central ethics review
board approved the study design.
Results: 1,281 people with migraine participated in the survey, 34.2%
with CM, 88.2% women, with an average age of 37.3 (SD 11.5). The
direct health costs for the last year were estimated at €3,847.29 for
CM and €964.19 for EM (p<0,001). The costs assumed by the patient
in the last year were €1,609.89 for CM and €878.04 for EM (p<0.001).
The indirect cost was estimated at €7,464.83 for CM and €3,199.15
for EM (p <0.001). The total average cost per patient/year rised to
€12,922.01 for CM and €5,041.41 for EM (p<0.001). Regarding the job
status: 62.2% with EM and 49.0% with CM were working, 2.6% with
EM and 9.1% with CM were on sick leave and 12.2% with EM and
16.8% with CM were unemployed (p <0.05). In the last year, because
of migraine, 17.8% of patients with EM and 27.2% with CM (p<0.01)
requested days of leave or leave of absence, and reduced their work-
ing hours 8.5% with EM and 11.1% CM (p=0.270). Labor efficiency
was reduced in 61.1% of patients with EM and 65.7% with CM
(p=0.257).
Conclusion: Migraine represents an important economic burden in
Spain, particularly in patients with CM. Migraine causes important
productivity losses resulting from absenteeism, presentism, decreas-
ing the working hours and the probabilities to keep working, and its
impact is significantly greater in CM.
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Objective
To analyse the evolution of a cohort of patients with migraine after
10 years, focusing on prognostic factors of improvement and
worsening.
Methods
Cross-sectional analysis of the cohort of migraine patients from the
Chromig study after 10 years. Using an online survey we collected
demographic data, comorbidities, characteristics, treatment, impact
of migraine (HIT-6, MIDAS, BDI, SF-36) and subjective impression of
evolution. Initial and after-10-years data was compared. A reduction
≥25% in headache days/month was considered as improvement. A
comparative study was carried out to identify predictors of improve-
ment or worsening.
Results
Data was collected from 380/1109 patients (34.3%): 77.1% women;
mean age 49.2 ± 10.5 years; 73.9% initial diagnosis of episodic mi-
graine (EM). After 10 years: patients have more arterial hypertension
(6.1% vs. 13.2%), less anxiety (57.5% vs. 22.9%) and depression
(36.1% vs. 13.9%) (p<0.05). A 20.8% of women have gone through
menopause. There is 66.8% reported subjective improvement of their
migraine. Mean frequency of headache improves (9.6±8.5 vs. 2.9±4.2
headache-days/month p<0.001), 80.7% decrease in frequency ≥25%,
(from these ten years ago, 43.3% had low-frequency EM; 24.6% high-
frequency EM; 23.9% chronic migraine; 8.2% chronic daily headache
(p<0.001)), which correlates with a lower proportion of high- fre-
quency EM (22.1% vs. 7.7%), chronic migraine (15.9% vs. 2.6%) and
chronic daily headache (6.6% 0 vs. 0.3%) (p <0.001); as well as with
an improvement in impact (HIT-6) and quality of life (SF-36) (p<0.05).
The factors associated with improvement are: baseline frequency
>10 days/month, change in routines and menopause onset (p<0.05).
In the multivariate analysis, the factor independently associated with
improvement is the baseline frequency >10 days/month (OR:1.268,
p=0.005). The factor associated with no improvement after 10 years
is going through mourning (p<0.05). As additional results of the ana-
lysis, we observed a reduction in the use of preventive treatment
(48.7% vs. 23.5%) and an increase in monotherapy (42.2% vs. 72.7%)
(p<0.001). 44.4% of patients don’t have a medical follow-up for their
migraine.
Conclusion
After 10 years, patients with migraine improve, especially those who
10 years ago had a high-frequency of headache days/month. Other
than the natural pathophysiology of migraine, the factors which cor-
relate with this improvement are a change in life habits and the on-
set of menopause.
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